ASCO Direct Highlights | Conference

Carving Out New Combination Therapies in Stem Cell Disorders

July 13th 2020

Despite the influx of novel agents that have received regulatory approval in recent years in stem cell disorders, there is still room for improvement.

Rini Reviews Key ASCO 2020 Highlights in Genitourinary Cancers

July 13th 2020

As part of the 2020 ASCO Direct Highlights™ webcast, Brian Rini, MD, discusses key developments in genitourinary cancers that were presented during the 2020 ASCO Virtual Scientific Program.

Postow Presents Progress Made in Melanoma

July 10th 2020

Immunotherapy and BRAF plus MEK inhibition are the key players in the treatment of patients with melanoma, Michael Postow, MD, said in a presentation during the 2020 ASCO Direct Highlights webcast.

Singal Speaks to ASCO Highlights in Rapidly Evolving HCC Paradigm

July 10th 2020

The treatment landscape of advanced hepatocellular carcinoma has been subject to rapid development in the last few years, says Amit G. Singal, MD, MS.

ASCO 2020 Heralds a Handful of Influential Data Across Breast Cancer Settings

July 10th 2020

The 2020 ASCO Virtual Scientific Program delivered a number of important updates to the field of breast cancer, explained Joyce A. O'Shaughnessy, MD.

ASCO 2020 Delivers Growing Insights on Supportive Care, Genetic Testing, and Symptom Management

June 30th 2020

Dawn L. Hershman, MD, MS, spotlights important data pertaining to cancer care delivery, prevention, symptom management, and survivorship that were presented at the 2020 ASCO Virtual Scientific Program.

Leonard Leads Discussion on Latest Developments in Leukemias and Lymphomas

June 26th 2020

Data in Richter’s transformation, Hodgkin lymphoma, Waldenström macroglobulinemia, and indolent lymphoma were presented at the 2020 ASCO Virtual Scientific Program, and although not entirely practice changing, are deserving of attention.

Brown Spotlights Key ASCO Highlights in Gynecologic Malignancies

June 26th 2020

The field of gynecologic oncology gained a number of important updates at the 2020 ASCO Virtual Scientific Program. As part of the ASCO Direct Highlights webcast, Jubilee Brown, MD, provided insight on key trials that were presented at the program.

Contemporary Considerations for Cancer Care in the COVID-19 Era

June 26th 2020

The downstream effects of the coronavirus disease 2019 on patients with cancer have become apparent over the past few months, and the onus is on the field to provide clinical guidance on best practices in the absence of definitive data.

Multiple Myeloma Paradigm Moves Forward With Promising Portfolio

June 25th 2020

There was no shortage of exciting developments at the 2020 ASCO Virtual Scientific Program in multiple myeloma. Peter Voorhees, MD, explained all of the pivotal data in myeloma therapeutics in a virtual presentation during the 2020 ASCO Direct Highlights webcast.

x